21.05.2019
- Novartis may be close to a billion-dollar settlement with the US government to resolve a whistleblower lawsuit accusing the Swiss pharmaceuticals giant of bribing doctors to boost...
17.05.2019
- US protein engineering company Codexis has signed a platform agreement with Novartis, granting the Swiss pharmaceutical producer a non-exclusive license to its proprietary...
13.05.2019
- To lighten its debt burden of more than $30 billion resulting from last year’s acquisition of Shire, Japanese pharma giant Takeda is selling Shire’s dry-eye drug Xiidra to...
17.04.2019
- Swiss drugmaker Novartis and US biopharma Amgen are embroiled in a legal dispute regarding their collaboration on migraine prevention drug Aimovig. Novartis has filed a complaint...
08.04.2019
- The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious...
03.04.2019
- Swiss drugmaker Novartis has agreed to buy US biotech IFM Tre in a deal worth nearly $1.6 billion, boosting its portfolio of anti-inflammatory medicines. Novartis will pay $310...
05.03.2019
- Novartis’ ill-advised attempt two years ago to get an inside look at drugs pricing policies of newly elected US president Donald Trump came back to haunt it last week during the...
19.11.2018
- After completing a portfolio review, Novartis has dropped around 20% of its R&D projects as it narrows its focus to the most cutting-edge medicines. Jay Bradner, president of the...
